
Taylor Morrison Home (TMHC) Earnings
Price: $59.98
Market Cap: $6.10B
Market Cap: $6.10B
Revenue (TTM): $8.17B
Net Income: $883.31M
Net Income: $883.31M
P/E Ratio: 7.07
EPS (TTM): $8.48
EPS (TTM): $8.48
Earnings Dates
Taylor Morrison Home (TMHC) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 23, 2025
- Time of Day: Before Market Open
- Estimated EPS: $1.85
Last Earnings Report
- Date: February 12, 2025
- EPS: $2.64
- EPS Estimate: $2.4
Taylor Morrison Home's next earnings report is scheduled for April 23, 2025.
In its last earnings report on February 12, 2025, Taylor Morrison Home reported earnings per share (EPS) of $2.64, compared to an estimated EPS of $2.40. The company reported revenue of $2.36B, compared to an estimated revenue of $2.13B.
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-12 | $2.40 | $2.64 |
Read Transcript | Q3 | 2024 | 2024-10-23 | $2.06 | $2.37 |
Read Transcript | Q2 | 2024 | 2024-07-24 | $1.90 | $1.97 |
Read Transcript | Q1 | 2024 | 2024-04-30 | $1.60 | $1.75 |
Read Transcript | Q4 | 2023 | 2024-02-14 | $1.74 | $1.58 |
Read Transcript | Q3 | 2023 | 2023-10-25 | $1.55 | $1.57 |
Read Transcript | Q2 | 2023 | 2023-07-26 | $1.68 | $2.12 |
Read Transcript | Q1 | 2023 | 2023-04-26 | $1.35 | $1.74 |
Read Transcript | Q4 | 2022 | 2023-02-15 | $2.69 | $2.68 |
Read Transcript | Q3 | 2022 | 2022-10-26 | $2.52 | $2.75 |
Read Transcript | Q2 | 2022 | 2022-07-27 | N/A | N/A |
Read Transcript | Q1 | 2022 | 2022-04-27 | N/A | N/A |
Read Transcript | Q4 | 2021 | 2022-02-08 | N/A | N/A |
Read Transcript | Q3 | 2021 | 2021-10-27 | N/A | N/A |
Read Transcript | Q2 | 2021 | 2021-07-31 | N/A | N/A |
Read Transcript | Q1 | 2021 | 2021-05-02 | N/A | N/A |
Read Transcript | Q4 | 2020 | 2021-02-10 | N/A | N/A |
Read Transcript | Q3 | 2020 | 2020-10-28 | N/A | N/A |
Read Transcript | Q2 | 2020 | 2020-08-01 | N/A | N/A |
Read Transcript | Q1 | 2020 | 2020-05-10 | N/A | N/A |
Read Transcript | Q4 | 2019 | 2020-02-05 | N/A | N/A |
Read Transcript | Q3 | 2019 | 2019-10-30 | N/A | N/A |
Read Transcript | Q2 | 2019 | 2019-08-03 | N/A | N/A |
Read Transcript | Q1 | 2019 | 2019-05-05 | N/A | N/A |
Read Transcript | Q4 | 2018 | 2019-02-13 | N/A | N/A |
Read Transcript | Q3 | 2018 | 2018-10-31 | N/A | N/A |
Read Transcript | Q2 | 2018 | 2018-08-01 | N/A | N/A |
Read Transcript | Q1 | 2018 | 2018-05-04 | N/A | N/A |
Read Transcript | Q4 | 2017 | 2018-02-07 | N/A | N/A |
Read Transcript | Q3 | 2017 | 2017-11-01 | N/A | N/A |
Read Transcript | Q2 | 2017 | 2017-08-02 | N/A | N/A |
Read Transcript | Q1 | 2017 | 2017-04-27 | N/A | N/A |
Read Transcript | Q4 | 2016 | 2017-02-08 | N/A | N/A |
Read Transcript | Q3 | 2016 | 2016-11-02 | N/A | N/A |
Read Transcript | Q2 | 2016 | 2016-08-03 | N/A | N/A |
Read Transcript | Q1 | 2016 | 2016-05-04 | N/A | N/A |
Earnings History
Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
---|---|---|---|---|
February 12, 2025 | $2.64 | $2.40 | $2.36B | $2.13B |
October 23, 2024 | $2.37 | $2.06 | $2.12B | $2.10B |
July 24, 2024 | $1.97 | $1.90 | $1.99B | $1.84B |
April 30, 2024 | $1.75 | $1.60 | $1.70B | $1.64B |
February 14, 2024 | $1.58 | $1.74 | $2.02B | $1.84B |
October 25, 2023 | $1.57 | $1.55 | $1.68B | $1.63B |
July 26, 2023 | $2.12 | $1.68 | $2.06B | $1.69B |
April 26, 2023 | $1.74 | $1.35 | $1.66B | $1.50B |
February 15, 2023 | $2.68 | $2.69 | $2.49B | $2.36B |
October 26, 2022 | $2.75 | $2.52 | $2.03B | $2.16B |
July 27, 2022 | $2.27 | $1.85 | $2.00B | $1.99B |
April 27, 2022 | $1.44 | $1.26 | $1.70B | $1.64B |
February 08, 2022 | $2.19 | $2.07 | $2.51B | $2.63B |
October 27, 2021 | $1.34 | $1.20 | $1.86B | $1.84B |
July 29, 2021 | $0.95 | $1.00 | $1.72B | $1.70B |
April 29, 2021 | $0.75 | $0.75 | $1.42B | $1.48B |
February 10, 2021 | $0.77 | $0.82 | $1.56B | $1.44B |
Annual Earnings
Annual Revenue
$8.17B
Fiscal Year 2024Annual Net Income
$883.31M
Fiscal Year 2024Annual EPS
$8.48
Fiscal Year 2024Quarterly Earnings
Revenue
$2.36B
Quarter Ending December 31, 2024Net Income
$242.45M
Quarter Ending December 31, 2024EPS
$2.33
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
13.86%
Year Ending December 31, 2024P/E Ratio
7.22
Year Ending December 31, 2024Revenue Per Share
$78.44
Year Ending December 31, 2024Earnings Yield (TTM)
14.14%
Trailing Twelve MonthsP/E Ratio (TTM)
7.07
Trailing Twelve MonthsRevenue Per Share (TTM)
$78.44
Trailing Twelve MonthsFrequently Asked Questions
Taylor Morrison Home's next earnings date is scheduled for April 23, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 12, 2025, Taylor Morrison Home reported earnings per share (EPS) of $2.64, compared to an estimated EPS of $2.40. The company reported revenue of $2.36B, compared to an estimated revenue of $2.13B.
Taylor Morrison Home's current Price-to-Earnings (P/E) ratio is 7.22. The trailing twelve months (TTM) P/E ratio is 7.07. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Taylor Morrison Home reported total revenue of $8.17B and net income of $883.31M. This represents a net profit margin of 0.1081408292.
Taylor Morrison Home's earnings yield is 13.86%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Taylor Morrison Home's return on equity (ROE) is 15.06%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Taylor Morrison Home's gross profit margin is 24.29%. This indicates that for every dollar of revenue, the company retains $0.24 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for TMHC.